COMMUNIQUÉS West-GlobeNewswire

ELSALYS BIOTECH acquiert auprès de JAZZ PHARMACEUTICALS les droits mondiaux de LEUKOTAC®
12/10/2017
ELSALYS BIOTECH acquiert auprès de JAZZ PHARMACEUTICALS les droits mondiaux de LEUKOTAC ® , un anticorps d'immunothérapie porteur de bénéfices cliniques dans la maladie aigüe cortico-résistante du greffon contre l'hôte [...]
Virbac : chiffre d'affaires du troisième trimestre impacté par des effets de déstockage dans la distribution aux Etats-Unis
12/10/2017
Virbac : chiffre d'affaires du troisième trimestre impacté par des effets de déstockage dans la distribution aux États-Unis Communiqué diffusé le 12 octobre 2017 Chiffre d'affaires consolidé trimestriel Le chiffre d' [...]
Virbac: quarterly sales affected by distributor destocking in the United States
12/10/2017
Virbac: quarterly sales affected by distributor destocking in the United States Public release - 12 October 2017 Consolidated quarterly sales Virbac sales for the third quarter reached €192.7 million, a decrease of -10. [...]
Ascom announces a strategic distribution partnership with GE Healthcare in Europe for intensive care units
12/10/2017
BAAR, Switzerland, Oct. 12, 2017 (GLOBE NEWSWIRE) -- Ascom (SWX:ASCN.SW) and GE Healthcare announce a strategic distribution partnership in Europe of Digistat Patient Watch solution. Designed specifically for Intensive [...]
Terveystalo Oyj - Managers' Transactions
12/10/2017
TERVEYSTALO PLC MANAGERS' TRANSACTIONS October 12, 2017 at 3:15 pm Terveystalo Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Karppi, [...]
Solon Eiendom ASA : Primary insider notification
12/10/2017
(Oslo, Norway, 12 October 2017) Solon Eiendom ASA Chairman of the Board Simen Thorsen (through his wholly owned company Hortulan AS) has today bought 78,325 shares in Solon Eiendom ASA at a price of NOK 18.40 per share [...]
Terveystalo Plc: Disclosure under Chapter 9, Section 5 of the Securities Markets Act
12/10/2017
TERVEYSTALO PLC STOCK EXCHANGE RELEASE October 12, 2017 at 2:15 p.m. Terveystalo Plc: Disclosure under Chapter 9, Section 5 of the Securities Markets Act Terveystalo Plc ("Terveystalo" or the "Company") has received a [...]
Zealand has initiated a clinical trial to evaluate the potential for less than once-daily dosing with its long-acting GLP-2 analog glepaglutide
12/10/2017
Press release - No. 9/2017 Zealand has initiated a clinical trial to evaluate the potential for less than once-daily dosing with its long-acting GLP-2 analog glepaglutide 30 subjects have already been dosed with [...]
Shire plc : Notice of Results
12/10/2017
Shire to announce third quarter 2017 results Dublin, Ireland - October 12, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG), will announce third quarter 2017 earnings on Friday October 27, 2017. Results press release will be [...]
New data showing paradoxical rise of inpatient CAD diagnostic testing presented at German Heart Days supports the implementation of Acarix CADScor®System
12/10/2017
Press release Malmö, October 12, 2017 New data showing paradoxical rise of inpatient CAD diagnostic testing presented at German Heart Days supports the implementation of Acarix CADScor®System Non-invasive acoustic [...]
Terveystalo Oyj - Managers' Transactions
12/10/2017
TERVEYSTALO PLC MANAGERS' TRANSACTIONS October 12, 2017 at 11:05 am Terveystalo Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Rihko, Matti [...]
Terveystalo Plc - Managers' Transactions
12/10/2017
TERVEYSTALO PLC MANAGERS' TRANSACTIONS October 12, 2017 at 11:00 am Terveystalo Plc - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Helsingin [...]
Terveystalo Oyj - Managers' Transactions
12/10/2017
TERVEYSTALO PLC MANAGERS' TRANSACTIONS October 12, 2017 at 11:00 am Terveystalo Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Laurila, [...]
Publishing of Orion Corporation's Interim Report for January-September 2017 on 26 October 2017
12/10/2017
ORION CORPORATION PRESS RELEASE 12 OCTOBER 2017 at 10.30 A.M. EEST Publishing of Orion Corporation's Interim Report for January-September 2017 on 26 October 2017 Orion will publish its Interim Report for January- [...]
Communiqué : Nouvelle avancée dans le rapprochement entre Essilor et Luxottica - Filialisation des activités d'Essilor
12/10/2017
Nouvelle avancée dans le rapprochement entre Essilor et Luxottica Filialisation des activités d'Essilor Version PDF du communiqué Charenton-le-Pont, France (le 12 octobre 2017 - 8h30) - Le 3 octobre 2017, le Conseil d' [...]
News Release: New achievement towards the combination of Essilor and Luxottica - Hive-down of Essilor's activities
12/10/2017
New achievement towards the combination of Essilor and Luxottica Hive-down of Essilor's activities PDF Version of the news release Charenton-le-Pont, France (October 12, 2017 - 8:30 a.m.) - On October 3, 2017, the Board [...]
Change in Nexstim Plc's Management Team
12/10/2017
Company announcement, Helsinki, 12 October 2017 at 9 AM. Change in Nexstim Plc's Management Team Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or " Company "), a medical technology company developing and marketing [...]
DBV Technologies Announces Completion of Blinded Period in REALISE Study of Viaskin Peanut
12/10/2017
Press Release Montrouge, France, October 12, 2017 DBV Technologies Announces Completion of Blinded Period in REALISE Study of Viaskin Peanut 97.5% of patients continue treatment in the open-label arm of the REALISE [...]
DBV Technologies annonce la fin de la première partie de l'étude REALISE de Viaskin Peanut
12/10/2017
Communiqué de presse Montrouge, France, le 12 octobre 2017 (7H30 CEST) DBV Technologies annonce la fin de la première partie de l'étude REALISE de Viaskin Peanut 97,5 % des patients poursuivent l'étude en ouvert et [...]

Pages